Acknowledgement
This research was supported by the BB21plus funded by Busan Metropolitan City and Busan Techno Park.
References
- Mirhadi S, Tam S, Li Q et al (2022) Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes. Nat Commun 13, 1811
- Sung HJ and Cho JY (2008) Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep 41, 615-625 https://doi.org/10.5483/BMBRep.2008.41.9.615
- Chen Y, Deng J, Liu Y et al (2021) Analysis of metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation. Ann Transl Med 9, 206
- Xu L, Lu C, Huang Y et al (2018) SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker. BMB Rep 51, 648-653 https://doi.org/10.5483/BMBRep.2018.51.12.205
- Mahmood MQ, Ward C, Muller HK, Sohal SS and Walters EH (2017) Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease. Med Oncol 34, 45
- Kalluri R and Weinberg RA (2010) The basics of epithelial-mesenchymal transition. J Clin Invest 120, 1786
- Stone RC, Pastar I, Ojeh N et al (2016) Epithelial-mesenchymal transition in tissue repair and fibrosis. Cell Tissue Res 365, 495-506 https://doi.org/10.1007/s00441-016-2464-0
- Leopold PL, Vincent J and Wang H (2012) A comparison of epithelial-to-mesenchymal transition and re-epithelialization. Semin Cancer Biol 22, 471-483 https://doi.org/10.1016/j.semcancer.2012.07.003
- Niu FY, Zhou Q, Yang JJ et al (2016) Distribution and prognosis of uncommon metastases from non-small cell lung cancer. BMC Cancer 16, 149
- Tamura T, Kurishima K, Nakazawa K et al (2015) Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mol Clin Oncol 3, 217-221 https://doi.org/10.3892/mco.2014.410
- Haynes J, Srivastava J, Madson N, Wittmann T and Barber DL (2011) Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression. Mol Biol Cell 22, 4750-4764 https://doi.org/10.1091/mbc.e11-02-0119
- Polioudaki H, Agelaki S, Chiotaki R et al (2015) Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer. BMC Cancer 15, 399
- Scanlon CS, Van Tubergen EA, Inglehart RC and D'Silva NJ (2013) Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res 92, 114-121 https://doi.org/10.1177/0022034512467352
- Shinomiya H (2012) Plastin family of actin-bundling proteins: its functions in leukocytes, neurons, intestines, and cancer. Int J Cell Biol 2012, 213492
- Garbett D, Bisaria A, Yang C et al (2020) T-plastin reinforces membrane protrusions to bridge matrix gaps during cell migration. Nat Commun 11, 4818
- Ueo H, Sugimachi K, Gorges TM et al (2015) Circulating tumour cell-derived plastin 3 is a novel marker for predicting long-term prognosis in patients with breast cancer. Br J Cancer 112, 1519-1526 https://doi.org/10.1038/bjc.2015.132
- Markou A, Lazaridou M, Paraskevopoulos P et al (2018) Multiplex gene expression profiling of in vivo isolated circulating tumor cells in high-risk prostate cancer patients. Clin Chem 64, 297-306 https://doi.org/10.1373/clinchem.2017.275503
- Kurashige J, Yokobori T, Mima K et al (2019) Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer. Oncol Lett 17, 2393-2399 https://doi.org/10.3892/ol.2018.9819
- Yokobori T, linuma H, Shimamura T et al (2013) Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res 73, 2059-2069 https://doi.org/10.1158/0008-5472.CAN-12-0326
- Zheng D, Duan H, Wang S et al (2018) FAK regulates epithelial-mesenchymal transition in adenomyosis. Mol Med Rep 18, 5461-5472 https://doi.org/10.3892/mmr.2018.9600
- Nurmagambetova A, Mustyatsa V, Saidova A and Vorobjev I (2023) Morphological and cytoskeleton changes in cells after EMT. Sci Rep 13, 22164
- Machado RAC, Stojevski D, De Landtsheer S et al (2021) L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness. Cell Commun Signal 19, 22
- Lambrechts A, Van Troys M and Ampe C (2004) The actin cytoskeleton in normal and pathological cell motility. Int J Biochem Cell Biol 36, 1890-1909 https://doi.org/10.1016/j.biocel.2004.01.024
- Lin CS, Park T, Chen ZP and Leavitt J (1993) Human plastin genes. Comparative gene structure, chromosome location, and differential expression in normal and neoplastic cell. J Biol Chem 268, 2781-2792 https://doi.org/10.1016/S0021-9258(18)53842-4
- Xin Z, Li D, Mao F et al (2020) PLS3 predicts poor prognosis in pancreatic cancer and promotes cancer cell proliferation via PI3K/AKT signaling. J Cell Physiol 235, 8416-8423 https://doi.org/10.1002/jcp.29685
- Zeisberg M and Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119, 1429-1437 https://doi.org/10.1172/JCI36183
- Zhang Y, Wang W, Min J et al (2023) ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression. Cell Rep 42, 112654
- Uygur B and Wu WS (2011) SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis. Mol Cancer 10, 139
- Jiang W, Pang XG, Wang Q, Shen YX, Chen XK and Xi JJ (2021) Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection. Clin Lung Cancer 13, 280-287 https://doi.org/10.1016/j.cllc.2011.11.005
- Zhao X and Guan JL (2011) Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev 63, 610-615 https://doi.org/10.1016/j.addr.2010.11.001
- Schlaepfer DD, Hauck CR and Sieg DJ (1999) Signaling through focal adhesion kinase. Prog Biophys Mol Biol 71, 435-478 https://doi.org/10.1016/S0079-6107(98)00052-2
- Lee BY, Timpson P, Horvath LG and Daly RJ (2015) FAK signaling in human cancer as a target for therapeutics. Pharmacol Ther 146, 132-149 https://doi.org/10.1016/j.pharmthera.2014.10.001
- Siesser PM and Hanks SK (2006) The signaling and biological implications of FAK overexpression in cancer. Clin Cancer Res 12, 3233-3237 https://doi.org/10.1158/1078-0432.CCR-06-0456
- Wang B, Qi X, Li D, Feng M, Meng X and Fu S (2016) Expression of pY397 FAK promotes the development of non-small cell lung cancer. Oncol Lett 11, 979-983 https://doi.org/10.3892/ol.2015.3992
- David O, Jett J, LeBeau H et al (2004) Phospho-AKT overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage. Clin Cancer Res 10, 6865-6871 https://doi.org/10.1158/1078-0432.CCR-04-0174
- Wolff L, Strathmann EA, Muller I et al (2021) Plastin 3 in health and disease: a matter of balance. Cell Mol Life Sci 78, 5275-5301 https://doi.org/10.1007/s00018-021-03843-5
- Swaminathan V, Kalappurakkal JM, Mehta SB et al (2017) Actin retrograde flow actively aligns and orients ligand-engaged integrins in focal adhesion. Proc Natl Acad Sci USA 114, 10648-10653 https://doi.org/10.1073/pnas.1701136114
- Toutant M, Costa A, Studler JM, Kadare G, Carnaud M and Girault JA (2002) Alternative splicing controls the mechanisms of FAK autophosphorylation. Mol Cell Biol 22, 7731-7743 https://doi.org/10.1128/MCB.22.22.7731-7743.2002